je.st
news
Allergan Board Turns Down Valeant Takeover Offer
2014-05-12 14:36:03| Biotech - Topix.net
Botox maker Allergan is rejecting a takeover bid from Valeant Pharmaceuticals, saying that the unsolicited $46 billion offer undervalues the company and carries significant risk.
Tags: board
offer
turns
takeover
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||